baber/WOPTO huggingface dataset:
Patent FI-964377-A0 (FI)
Inventor: RETULAINEN ELIAS
IPC: D21F5/00
Filed: 1996-10-30
Abstract: The invention relates to an apparatus for drying a fiber web, in which apparatus the fiber web (5) is dried between two tight bands (1, 2) moving in the same direction and turning around turning rolls (6a, 6b, 7a, 7b). The first band (1) is heated by means of a pressure chamber (9) and the second band (2) is cooled by means of a water chamber (10). The fiber web (5) is led together with at least one felt or wire (3, 4) through a drying zone formed by the bands (1, 2) in such a way that the fiber web is in contact with the surface of the first band (1) and the felt or wire (3, 4) is between the fiber web (5) and the cooled second band (2). The surface (11) of the first band (1) bearing against the fiber web (5) is at least partially formed in such a way that reflection from it to a specular reflection angle is reduced substantially. Excessive gloss can then be removed from the surface of the fiber web (5) and the end product to be manufactured of it.
Patent FI-964780-A0 (FI)
Inventor: SCHMID RAIMUND
IPC: G07D7/00
Filed: 1996-11-29
Abstract: PCT No. PCT/EP95/01871 Sec. 371 Date Dec. 2, 1996 Sec. 102(e) Date Dec. 2, 1996 PCT Filed May 17, 1995 PCT Pub. No. WO95/33009 PCT Pub. Date Dec. 7, 1995Interference pigments based on titanium dioxide-coated silicatic platelets which have been heated in a reducing atmosphere are useful for producing forgeryproof documents and packaging.
Patent FI-991240-A0 (FI)
Inventor: LAPPETELAEINEN ANTTI
IPC: H04L29/06
Filed: 1999-06-01
Abstract: The invention relates to a method in a wireless communication system (1) comprising wireless terminals (MT1-MT4), a communication channel (CH) and at, least one access point (AP1, AP2) and access point controller (AC1, AC2). The method comprises the steps of activating at least one data transmission connection between the wireless terminal (MT1-MT4) and the access point (AP1), in which information is transmitted in packets, forming data frames (FR) for the transmission of the packets, supplementing said data frame (FR) with at least one item of error checking data, in whose formation at least a part of the information contained in the data frame (FR) is used, converting said data frames (FR) into signals to be transmitted on the communication channel, receiving signals transmitted on the communication channel and converting them into data frames, forming reference.data corresponding to at least one item of error checking data on the basis of the information received in the data frame (FR), comparing the received error checking data with said reference data, and setting up an acknowledgement message, in which information on the received parts of the data frame (FR) is transmitted from the device (MT1-MT4) receiving the data frames to the device (AP1, AP2).
Patent FI-991302-A0 (FI)
Inventor: FOSTER TODD P
IPC: A61K47/44
Filed: 1999-06-08
Abstract: The present invention provides for the inclusion of small amounts of water in oil suspensions of active drugs, such as ceftiofur hydrochloride of formula I. The resulting suspensions have improved resuspendability. Improved resuspendability results in an improved product because less shaking of the suspension is required before dosing.    <IMAGE>  I
Patent IL-64034-A0 (IL)
Title: Production of n-substituted derivatives of 1-desoxynojirimicin
IPC: C07C271/16
Filed: 1981-10-12
Abstract: A process has been developed for the preparation of compounds of the formula    <IMAGE>  (I)  wherein R is hydrogen or an optionally substituted alkyl radical, which comprises reacting glucose with a compound of the formula H2N-R wherein R has the meaning given above to form a 1-amino-sorbitol of the formula    <IMAGE> (IV)  wherein R has the meaning given above, reacting said 1-aminosorbitol with a compound providing a protective group which can be split off under acid conditions and is stable in the subsequent microbiological oxidation process, aerobically oxidizing the compound thus obtained microbiologically to give a protected 6-aminosorbose, splitting off the protective group under acid conditions and hydrogenating the 6-aminosorbose salt thus obtained either after being isolated or in one operation, to give the compound of the formula (I). The products obtained by the process of the invention are useful as  alpha -glucoside inhibitors.
Patent IL-66384-A0 (IL)
Title: Sulphimines and salts thereof,their preparation and pharmaceutical compositions containing them
IPC: C07D409/12
Filed: 1982-07-23
Abstract: Compounds of the formula   <IMAGE>   wherein n is 0 or 1; A is methylene, vinylene or ethylene optionally substituted by lower alkyl; B is alkylene; R1 is an optionally substituted alkyl, phenyl or naphthyl group, or a cycloalkyl or pyridyl group; and R2 is hydrogen or acyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as antithrombotics.
Patent IL-67285-A0 (IL)
Title: Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D/
Filed: 1982-11-17
Abstract: The present invention relates to new cephalosporins of general formula    <IMAGE>  (II)  in which R1=R2=CH3 or R1 and R2 together form a 1,3-propylene group, A is H, a cation, an ester or a hemiacetal, and R3 is a heterocycle comprising five or six atoms including at least one atom in the ring of nitrogen. It also relates to a process for preparing these cephalosporins and to the drugs containing them.
Patent IL-79271-A0 (IL)
Title: High yield production of swine growth hormone
IPC: C12P21/02
Filed: 1986-06-27
Abstract: A high-density fermentation process for high yield production of a protein having swine growth hormone activity by transformant E. coli strains is described. The process employs transformant stains of E. coli containing a gene coding for a protein having swine growth hormone activity under the control of a bacteriophage lambda promoter-operator and a gene coding for the λc1857 temperature-sensitive repressor protein. In the initial growth period, the level of dissolved oxygen in the fermentation medium is maintained at about 20 % to 60 % of saturation and the temperature of the medium is maintained at a temperature at which the λ c1857 repressor protein is active. Production of the desired protein is then induced by raising the temperature of the medium to at least about 42°C. The temperature is then reduced to about 38°C to 41°C to optimize cell growth for the remainder of the induction period, during which the level of dissolved oxygen in the medium is maintained at about 10% to 40 % saturation, and the protein having swine growth hormone activity thus produced is recovered from the transformant cells.
Patent IL-80172-A0 (IL)
Title: Sulphonylphenylalkylamines,processes for the preparation thereof and pharmaceutical compositions containing them
IPC: A61P7/02
Filed: 1986-09-28
Abstract: 1. Sulphonylphenylalkylamines of the formula II   see diagramm : EP0221344,P23,F2   in which R1 represents an alkyl group with 1-6 C-atoms, a cycloalkyl radical with 3-7 C-atoms, an aralkyl, aralkenyl or aryl radical, whereby the aryl moiety can, in each case, be substituted one or more times by halogen, C1 -C6 -alkyl, C1 -C6 -alkoxy, hydroxyl, trifluoromethyl, cyano, nitro, amino, C1 -C6 -alkylamino, C2 -C12 -dialkylamino, C1 -C6 -acylamino, C1 -C16 -acyl or azide, R2 represents a hydrogen atom, an alkyl group with 1-6 C-atoms, an acyl group, an aralkyl or aralkyl or aralkenyl radical, whereby the aryl moiety can, in each case, be substituted one or more times by halogen, C1 -C6 -alkyl, C1 -C6 -alkoxy, hydroxyl, trifluoromethyl, cyano, nitro, amino, C1 -C6 -alkylamino, C2 -C12 - dialkylamino, C1 -C6 -acylamino, C1 -C16 -acyl or azide, B an unbranched or branched alkylene chain with a maximum of 4 C-atoms and A represents an alkyl or alkenyl group with 1-6 C-atoms, a C1 -C6 - formylalkyl radical, a C1 -C6 -hydroxyalkyl group or a radical -D-R3 , in which D signifies a -CO- or -CHOH- group and R3 hydrogen, a C1 -C5 -alkyl, a C1 -C5 - hydroxyalkyl or a C1 -C5 -alkylcarboxylic acid radical, as well as their pharmacologically acceptable salts and their esters, amides and lactones, insofar as these compounds contain a carboxyl group or a hydroxyl and a carboxyl group, with the proviso that for the case that R2 signifies a hydrogen atom or a C1 -C5 -alkyl group and B represents a straight-chained C1 -C3 -alkylene chain A can then only be an alkyl or alkenyl group with 1-6 C-atoms.
Patent IL-83604-A0 (IL)
Title: Phosphinothricin-resistance gene,and its use
IPC: C12N15/54
Filed: 1987-08-21
Abstract: Selection of Streptomyces viridochromogenes DSM 4112 using phosphinothricyl-alanyl-alanine (PTT) results in PTT-resistant selectants. Subjecting the total DNA of these selectants to cutting with Bam HI, cloning of a 4.0 kb fragment and selection for PTT resistance result in the DNA fragment which harbours the phosphinothricin (PTC)-resistance gene. The latter is suitable for producing PTC-resistant plants, and as resistance marker and for the selective N-acetylation of the L form of racemic PTC. <IMAGE>
Patent IL-94984-A0 (IL)
Title: Melamine-containing photoresists of improved sensitivity
IPC: H01L21/027
Filed: 1990-07-05
Abstract: Melamine-containing photoresists are disclosed that display increased sensitivity, measured as lithographic potential, when compared to known photoresists that contain melamine resin as a crosslinker. The melamine resin in these photoresists contains a higher percent, by weight, of monomeric hexamethoxymethylmelamine than in known resists.
Patent IL-96537-A0 (IL)
Title: Reaction and solubilizing medium of peptides and process of preparation employing the same
IPC: C07K1/06
Filed: 1990-12-04
Abstract: Reaction and solubilising medium for the synthesis of peptides. This reaction and solubilising medium for the synthesis and/or purification of peptides comprises a diluent A chosen from the group of water-immiscible solvents and a phenol B. Application to the synthesis of peptides which are optionally employed for the synthesis of medications, vaccines or agri-foodstuff or plant-protection products.
Patent IL-97054-A0 (IL)
Title: Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
IPC: A61P25/00
Filed: 1991-01-25
Abstract: Buspirone and its pharmaceutically acceptable salts are useful in the treatment of sleep apneas.
Patent SE-8901361-A0 (SE)
Title: Sätt att modifiera ett bindemedel
Inventor: LUNDSTRÖM CLAES
IPC: C04B40/00
Filed: 1989-04-17
Abstract: Satt an modifiera ett bindemedel for att anpassa detta till att Oka 5 reaktionsbenagenheten med andra material. Bindemedlet innefattar kiseldioxid, som pa i sig kant satt loses och aterbildas under bildande av en. hardad eller pr lymeriserad kropp, dvs ett sá kallat polymert silikat av den huvudtyp som principiellt inbegriper vattenglas och kvarts (Si02) finfordelad form, samt med tillsats av en aktiv kiselfOrening i form av 10 hogdisperserad, finfordelad, amorf/polymer Si02 fore hardning eller polymerisation i en kvantitet mellan 3-5 viksprocent, b,eraknad pa den sammaniagda torrvikten av de ingiende amnena, samt ett vattenabsorberande och hardande medel, sasom exempelvis natriumhexafluorosilikat. 15Sattet enligt uppfinningen bestar i att fore eller under hela eller delar av bindemedlets hardande eller polymerisation fOrandres dettas anjon-katjonhalt och/eller fordelning i relation till det eller de material, som skall bindas av bindemedlet, eller omvant fOrandras det eller de materials, som skall bindas av bindemedlet, anjon-katjonhalt och/eller_fOrdelning eller att 20 en kombination av dessa itgarder vidtages. Namnda anjon-katjonhalt avpassas sã att vasentligen inget overskott av namnda anjon-katjonhalt foreligger efter hardande eller polymerisation.
Patent SE-8904155-A0 (SE)
Title: Husbyggnadskonstruktion
Inventor: GRUDEBORN LARS-OWE
IPC: E04H3/02
Filed: 1989-12-11
Abstract: 2 sArskilt markerat vid stora hotellbyggnationer, dAr namnda avstand ofta ãr avsevarda. Vidare kan konventionella rektangulara rum ofta ge (At trAngt och begransat intryck sett frAn rummets entredorr, vilket hr sarskilt ogynnsamt vid exempelvis hotellrum. Umfinningens svfte: Syftet med fOreliggande uppf inning är att undanroja ovannAmnda problem genom att istadkomma en synnerligen kostnadseffektiv husbyggnadskonstruktion, i vilken kommunikationsytor begransas till ett minimum varigenom optimal rumsyta erhalles samridigt sommaterialkostnadenminimeras genom starkt begransat behov av kommunikationsytorna angransande vaggsektioner och genom avsevart forenklat vatton-, el- och ventilationssystem. Sammanfattning av uppfinningen: Ovannamnda syfte uppnAs genom att foreliggande uppfinning tillhandahAller en byggnadskonstruktion, omfattande separat byggnadskropp eller flera byggnadskroppar antingen anordnade I flera plan, i samma plan forbundna med -arandra eller i en kombination harav. Uppfinningen hanfor sig sarskilt till att varje enskild byggnadskropp är utformad som en mAnghorning, vars kantsidor utg6r yttervaggar for medelst mellanvaggar sektorindelade rumsenheter. Namnda rumsenheter begransas i riktning radiellt mat byggnad3kroppens centrum av innervhggar. Innervdggarnas mat centrum vdnda ytor definierar vidare ett centralt kommunikationsutrymme forbundet i Atminstone en byggnadskropp med en radiellt utAt mynnande kommunikationsv&g. en foredragen utforingsform av uppfinningen är den av byggnadskroppendefinierademAnghorningenihuvudsaksymmetrisk relativt ett centrum, och ndmnda kommunikationsvag stracker sig radiellt utAt och utmynnar i byggnadskroppens yttervagg.
Patent AU-PR695601-A0 (AU)
Title: Message transmission between telecommunications network entities
IPC: H04L29/06
Filed: 2001-08-10
Abstract: The invention refers to a method for transporting a media gateway control protocol message to a media gateway is disclosed, wherein the media gateway control protocol message is adapted to a dedicated maximum transmission unit MTU, comprising the segmenting of the media gateway control protocol message, if it exceeds the MTU. The step of segmenting is invoked prior to the media gateway control protocol message being passed to a transport layer in a media gateway controller. Further the invention refers to a corresponding reassembly of the media gateway control protocol message, to a corresponding Media Gateway Controller and Media Gateway.
Patent IL-101561-A0 (IL)
Title: Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
IPC: C07D295/185
Filed: 1992-04-10
Abstract: The compounds of the formula <IMAGE> in which A, R<1>, R<2>, R<3>, R<4> and R<5> have the meaning given in Claim 1, in the form of optically pure diastereomers, diastereomer mixtures, diastereomeric racemates or mixtures of diastereomeric racemates and pharmaceutically utilisable salts thereof inhibit the action of the natural enzyme renin and can accordingly be used in the form of pharmaceutical preparations in the control or prevention of high blood pressure and cardiac insufficiency. They can be prepared by various processes known per se.
Patent IL-109728-A0 (IL)
Title: Indoles
IPC: A61P35/00
Filed: 1994-05-23
Abstract: PCT No. PCT/EP94/01760 Sec. 371 Date Nov. 16, 1995 Sec. 102(e) Date Nov. 16, 1995 PCT Filed May 26, 1994 PCT Pub. No. WO94/27990 PCT Pub. Date Dec. 8, 1994Compounds of formula (I)   <IMAGE>   and the pharmaceutically acceptable base salts thereof, wherein R is -CO2H or tetrazol-5 yl; R1 is C3-C8alkyl optionally substituted by fluoro; and R2 is C2-C4alkyl, together with compositions containing, uses of, process for the preparation of, and intermediates used in the preparation of, such compounds. The compounds have steroid 5 alpha -reductase inhibitory activity and are useful for treating a disease such as benign prostatic hypertrophy.
Patent IL-112963-A0 (IL)
Title: A pharmaceutical composition containing gamma globulins or fragments thereof
IPC: A61P35/00
Filed: 1995-03-12
Abstract: This invention provides therapeutic methods for inhibiting tumor metastasis and for treating primary tumors. The methods of this invention do not cause serious side effects and will be effective for a broad spectrum of cancerous diseases. In particular, the invention discloses a novel method comprising administering to a mammal a preparation of intravenous immunoglobulin (IVIG). The IVIG preparation to be administered according to this invention may contain intact immunoglobulin molecules or fragments of immunoglobulins. The preparation is administered parenterally, preferably via intravenous, intracavitary or subcutaneous routes, either as a sole agent or in combination with other agents or methods which are commonly used for cancer treatment.
Patent IL-125944-A0 (IL)
Title: Proton pump inhibitor
IPC: A61K31/4188
Filed: 1997-02-26
Abstract: Novel thiadiazole compounds are provided, which are effective as proton pumps inhibitors, useful in treating peptic ulcers by inhibition of the proton pump enzyme H+/K+-ATPase. The compounds are 3-substituted 1,2,4-thiadiazolo [4,5- alpha ]benzimidazole and 3-substituted imidazo[1,2-d]-1,2,4-thiadiazoles corresponding to the general formula:   <IMAGE>   where X and Z either represent an optionally substituted benzene ring fused to the diazole nucleus, or represent a variety of independent chemical groupings (hydrogen, lower alkyl, halo, etc.) and Y is an electronegative group.
Patent IL-127248-A0 (IL)
Title: A method for producing a micromotor
IPC: A61M60/531
Filed: 1998-03-31
Abstract: PCT No. PCT/EP98/01867 Sec. 371 Date Dec. 1, 1998 Sec. 102(e) Date Dec. 1, 1998 PCT Filed Mar. 31, 1998 PCT Pub. No. WO98/44619 PCT Pub. Date Oct. 8, 1998A micro motor is manufactured by slipping the parts (24a, 24b) of a stator (24) on the mandrel (60) which is placed into an injection mold (50). The motor housing is made by injecting polymer material (63), the stator parts (24a, 24b) being encapsulated in the housing. During injection, a bearing (27) is contained in the injection mold (50). Subsequently, the mandrel (60) is drawn from the stator and a prepared rotor is inserted. Thus, a cost effective and high-precision manufacture of an electric motor with very small dimensions is made possible.
Patent IL-127964-A0 (IL)
Title: A method for determining the efficacy of active agents
IPC: G01N33/48
Filed: 1997-07-10
Abstract: An improved system for assaying expression of various markers, factors or antigens on the cultured cells for diagnostic purposes and for using such expression to monitor the applicability of certain candidate therapeutic or chemotherapeutic agents and the progress of treatment with those agents.
Patent IL-136540-A0 (IL)
Title: Container for an inhalation anesthetic
IPC: A61K9/48
Filed: 1999-01-08
Abstract: A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
Patent IL-144259-A0 (IL)
Title: Methods for making proteins containing free cysteine residues
IPC: C07K14/72
Filed: 2000-01-14
Abstract: The present invention relates to novel methods of making soluble proteins having free cysteines in which a host cell is exposed to a cysteine blocking agent. The soluble proteins produced by the methods can then be modified to increase their effectiveness. Such modifications include attaching a PEG moiety to form pegylated proteins.
Patent IL-148804-A0 (IL)
Title: Substrate-guided optical device
IPC: G02B1/00
Filed: 2002-03-21
Abstract: The invention relates to an optical device, comprising a light-transmitting substrate (20) having at least two major surfaces and edges; optical means for coupling light into said substrate (20) by total internal reflection; and at least one partially reflecting surface (22) located in said substrate (20).
Patent IL-179551-A0 (IL)
Title: Injection device
IPC: A61M5/20
Filed: 2006-11-23
Abstract: An injection device (110) is described having a housing (112) that receives a syringe (114) having a needle (118), wherein the syringe is supported in a syringe carrier (150). The syringe and syringe carrier are biased by a return spring (126) from an extended position in which the needle (118) extends from the housing (112) through an exit aperture (128) to a retracted position in which it does not. A drive spring (130) acts via a drive to advance the syringe from its retracted position to its extended position and discharge its contents through the needle and a return spring, brought into play when the drive has reached a nominal return position, restores the syringe to its retracted position.
Patent IL-181461-A0 (IL)
Title: Membrane pump with air release valve
Filed: 2007-02-20
Abstract: Suction pump comprises a ventilating valve having a ventilating body which is operated in such a way that it releases only a partial region of a ventilating opening when the valve is open and subsequently releases a larger region or the whole ventilating opening. An independent claim is also included for a method for operating a suction pump. Preferred Features: The ventilating body s a ventilating membrane having an edge region. The ventilating membrane is connected to an anchor of a lifting magnet via a connecting pin. The connecting pin is arranged over one corner of the ventilating opening.
Patent IL-183228-A0 (IL)
Title: A shielded and sealed lelctric harness
IPC: H01R13/658
Filed: 2007-05-15
Abstract: The harness has conductive elements with connectors/branches at its ends, where each element has an electrically conducting wire (20) mounted in a tubular structure (22) of protection and shield. The structure has a sheath (28) with ringed structure, surrounding a metallic tubular braid (26) of the shield. An end of the sheath is fixed to a cylindrical end fitting (30) of thermo-retractable material. The end fitting fixes the sheath on the connector, and locks and fixes an end of the braid on a cylindrical piece (32) of the connector by intermediate of a metallic band (36).
Patent IL-193814-A0 (IL)
Title: 1 -acetyl- 3,3 dimethyl- 6- amino- 2, 3 - dihydroindole and process for producing same
IPC: C07D409/04
Filed: 2008-09-01
Abstract: Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Patent IL-197773-A0 (IL)
Title: A process for the production of a piperidin -4-one derivative
Filed: 2009-03-24
Abstract: Provided is a method for producing a piperidin-4-one derivative useful as an intermediate for agricultural chemicals or pharmaceutical products. A piperidin-4-one derivative represented by formula (III-a) or formula (III-b) is produced by reacting a cyclic bis(aminol)ether compound represented by formula (I) and an acetone derivative represented by formula (II) in the presence of at least one substance selected from the group consisting of protonic acids, Lewis acids, acid halides and dialkyl sulfuric acids.